<DOC>
	<DOCNO>NCT02802150</DOCNO>
	<brief_summary>The purpose study evaluate clinical efficacy safety 10-weeks oral consumption Zanthoxylum schinifolium seed Oil ( ZSO ) patient mild dry eye disease .</brief_summary>
	<brief_title>The Effect Oral Zanthoxylum Schinifolium Seed Oil Individuals With Dry Eye Disease</brief_title>
	<detailed_description>In double-blind , randomize placebo-controlled trial , twenty participant experience dry eye symptom recruit , randomly assign consume 4 g/day either ZSO soy bean oil ( SBO ) placebo 10 week . All participant complete study . Follow-ups dry eye symptom objective sign , inflammatory oxidative stress marker , blood lipid analysis perform .</detailed_description>
	<mesh_term>Keratoconjunctivitis Sicca</mesh_term>
	<mesh_term>Dry Eye Syndromes</mesh_term>
	<mesh_term>Eye Diseases</mesh_term>
	<criteria>Inclusion criterion : men woman 20 70 year dry eye disease low tear breakup time ( TBUT ) ( &lt; 10 second ) low Schirmer score ( application local anesthetic ) ( &lt; 10mm 5 min ) presence corneal conjunctival damage time screen . blood level triglyceride high 150 mg/dL HDLcholesterol less 40 50 mg/dL men woman , respectively . antiinflammatory eye drop dry eye ( topical steroid topical cyclosporin ) hypolipidemic medication within 3 month study entry history chronic disease clinical trial use investigative medicinal product within 2 month first dose present study allergic hypersensitive ingredient test product . woman pregnant breast feed history alcoholism drug abuse medical psychological condition</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>Zanthoxylum schinifolium seed Oil</keyword>
	<keyword>soy bean oil</keyword>
	<keyword>omega-3 fatty acid</keyword>
	<keyword>dry eye disease</keyword>
</DOC>